Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients
Gespeichert in:
| Veröffentlicht in: | Journal of neurology 2013, Vol.260 (1), p.327-329 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 329 |
|---|---|
| container_issue | 1 |
| container_start_page | 327 |
| container_title | Journal of neurology |
| container_volume | 260 |
| creator | Ghezzi, A. Rocca, M. A. Baroncini, D. Annovazzi, P. Zaffaroni, M. Minonzio, G. Comi, G. Filippi, M. |
| description | |
| doi_str_mv | 10.1007/s00415-012-6744-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2732894363</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2732894363</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-e718510dcc5e1a91e148af07c7fc4c7e974f680fdf48f077dca58d0613ffc0d03</originalsourceid><addsrcrecordid>eNp1kE1LxDAQhoMo7rr6A7xIwXN00qRNe5T1Exa8KHgLMR9Llm5ak1Tx35ulfpw8Dcw8887wIHRK4IIA8MsIwEiFgZS45oxhvofmhNESE1a1-2gOlAGuaMVm6CjGDQA0eXCIZiUlNWE1zNHLtYtGRlMEI1Vy7zK53hfSJhMK6_y679y214V2UfU-OT9OgPNF-uiL7dglN3SmiKozoY8uFkMGjE_xGB1Y2UVz8l0X6Pn25ml5j1ePdw_LqxVWlLYJG06aioBWqjJEtsQQ1kgLXHGrmOKm5czWDVhtWZPbXCtZNRpqQq1VoIEu0PmUO4T-bTQxiU0_Bp9PipLTsmkZrWmmyESp_GUMxoohuK0Mn4KA2LkUk0uRXYqdS8Hzztl38vi6Nfp340deBsoJiHnk1yb8nf4_9QvDW4C9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2732894363</pqid></control><display><type>article</type><title>Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Ghezzi, A. ; Rocca, M. A. ; Baroncini, D. ; Annovazzi, P. ; Zaffaroni, M. ; Minonzio, G. ; Comi, G. ; Filippi, M.</creator><creatorcontrib>Ghezzi, A. ; Rocca, M. A. ; Baroncini, D. ; Annovazzi, P. ; Zaffaroni, M. ; Minonzio, G. ; Comi, G. ; Filippi, M.</creatorcontrib><identifier>ISSN: 0340-5354</identifier><identifier>EISSN: 1432-1459</identifier><identifier>DOI: 10.1007/s00415-012-6744-7</identifier><identifier>PMID: 23161460</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Adult ; Disability Evaluation ; Female ; Fingolimod Hydrochloride ; Humans ; Immunosuppressive Agents - administration & dosage ; Letter to the Editors ; Magnetic Resonance Imaging ; Medicine ; Medicine & Public Health ; Middle Aged ; Multiple sclerosis ; Multiple Sclerosis - drug therapy ; Neurology ; Neuroradiology ; Neurosciences ; Propylene Glycols - administration & dosage ; Recurrence ; Sphingosine - administration & dosage ; Sphingosine - analogs & derivatives ; Substance Withdrawal Syndrome - drug therapy ; Substance Withdrawal Syndrome - etiology</subject><ispartof>Journal of neurology, 2013, Vol.260 (1), p.327-329</ispartof><rights>Springer-Verlag Berlin Heidelberg 2012</rights><rights>Springer-Verlag Berlin Heidelberg 2012.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-e718510dcc5e1a91e148af07c7fc4c7e974f680fdf48f077dca58d0613ffc0d03</citedby><cites>FETCH-LOGICAL-c339t-e718510dcc5e1a91e148af07c7fc4c7e974f680fdf48f077dca58d0613ffc0d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00415-012-6744-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00415-012-6744-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23161460$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ghezzi, A.</creatorcontrib><creatorcontrib>Rocca, M. A.</creatorcontrib><creatorcontrib>Baroncini, D.</creatorcontrib><creatorcontrib>Annovazzi, P.</creatorcontrib><creatorcontrib>Zaffaroni, M.</creatorcontrib><creatorcontrib>Minonzio, G.</creatorcontrib><creatorcontrib>Comi, G.</creatorcontrib><creatorcontrib>Filippi, M.</creatorcontrib><title>Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients</title><title>Journal of neurology</title><addtitle>J Neurol</addtitle><addtitle>J Neurol</addtitle><subject>Adult</subject><subject>Disability Evaluation</subject><subject>Female</subject><subject>Fingolimod Hydrochloride</subject><subject>Humans</subject><subject>Immunosuppressive Agents - administration & dosage</subject><subject>Letter to the Editors</subject><subject>Magnetic Resonance Imaging</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Multiple sclerosis</subject><subject>Multiple Sclerosis - drug therapy</subject><subject>Neurology</subject><subject>Neuroradiology</subject><subject>Neurosciences</subject><subject>Propylene Glycols - administration & dosage</subject><subject>Recurrence</subject><subject>Sphingosine - administration & dosage</subject><subject>Sphingosine - analogs & derivatives</subject><subject>Substance Withdrawal Syndrome - drug therapy</subject><subject>Substance Withdrawal Syndrome - etiology</subject><issn>0340-5354</issn><issn>1432-1459</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kE1LxDAQhoMo7rr6A7xIwXN00qRNe5T1Exa8KHgLMR9Llm5ak1Tx35ulfpw8Dcw8887wIHRK4IIA8MsIwEiFgZS45oxhvofmhNESE1a1-2gOlAGuaMVm6CjGDQA0eXCIZiUlNWE1zNHLtYtGRlMEI1Vy7zK53hfSJhMK6_y679y214V2UfU-OT9OgPNF-uiL7dglN3SmiKozoY8uFkMGjE_xGB1Y2UVz8l0X6Pn25ml5j1ePdw_LqxVWlLYJG06aioBWqjJEtsQQ1kgLXHGrmOKm5czWDVhtWZPbXCtZNRpqQq1VoIEu0PmUO4T-bTQxiU0_Bp9PipLTsmkZrWmmyESp_GUMxoohuK0Mn4KA2LkUk0uRXYqdS8Hzztl38vi6Nfp340deBsoJiHnk1yb8nf4_9QvDW4C9</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Ghezzi, A.</creator><creator>Rocca, M. A.</creator><creator>Baroncini, D.</creator><creator>Annovazzi, P.</creator><creator>Zaffaroni, M.</creator><creator>Minonzio, G.</creator><creator>Comi, G.</creator><creator>Filippi, M.</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>2013</creationdate><title>Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients</title><author>Ghezzi, A. ; Rocca, M. A. ; Baroncini, D. ; Annovazzi, P. ; Zaffaroni, M. ; Minonzio, G. ; Comi, G. ; Filippi, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-e718510dcc5e1a91e148af07c7fc4c7e974f680fdf48f077dca58d0613ffc0d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Disability Evaluation</topic><topic>Female</topic><topic>Fingolimod Hydrochloride</topic><topic>Humans</topic><topic>Immunosuppressive Agents - administration & dosage</topic><topic>Letter to the Editors</topic><topic>Magnetic Resonance Imaging</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Multiple sclerosis</topic><topic>Multiple Sclerosis - drug therapy</topic><topic>Neurology</topic><topic>Neuroradiology</topic><topic>Neurosciences</topic><topic>Propylene Glycols - administration & dosage</topic><topic>Recurrence</topic><topic>Sphingosine - administration & dosage</topic><topic>Sphingosine - analogs & derivatives</topic><topic>Substance Withdrawal Syndrome - drug therapy</topic><topic>Substance Withdrawal Syndrome - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ghezzi, A.</creatorcontrib><creatorcontrib>Rocca, M. A.</creatorcontrib><creatorcontrib>Baroncini, D.</creatorcontrib><creatorcontrib>Annovazzi, P.</creatorcontrib><creatorcontrib>Zaffaroni, M.</creatorcontrib><creatorcontrib>Minonzio, G.</creatorcontrib><creatorcontrib>Comi, G.</creatorcontrib><creatorcontrib>Filippi, M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Journal of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghezzi, A.</au><au>Rocca, M. A.</au><au>Baroncini, D.</au><au>Annovazzi, P.</au><au>Zaffaroni, M.</au><au>Minonzio, G.</au><au>Comi, G.</au><au>Filippi, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients</atitle><jtitle>Journal of neurology</jtitle><stitle>J Neurol</stitle><addtitle>J Neurol</addtitle><date>2013</date><risdate>2013</risdate><volume>260</volume><issue>1</issue><spage>327</spage><epage>329</epage><pages>327-329</pages><issn>0340-5354</issn><eissn>1432-1459</eissn><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>23161460</pmid><doi>10.1007/s00415-012-6744-7</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0340-5354 |
| ispartof | Journal of neurology, 2013, Vol.260 (1), p.327-329 |
| issn | 0340-5354 1432-1459 |
| language | eng |
| recordid | cdi_proquest_journals_2732894363 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Adult Disability Evaluation Female Fingolimod Hydrochloride Humans Immunosuppressive Agents - administration & dosage Letter to the Editors Magnetic Resonance Imaging Medicine Medicine & Public Health Middle Aged Multiple sclerosis Multiple Sclerosis - drug therapy Neurology Neuroradiology Neurosciences Propylene Glycols - administration & dosage Recurrence Sphingosine - administration & dosage Sphingosine - analogs & derivatives Substance Withdrawal Syndrome - drug therapy Substance Withdrawal Syndrome - etiology |
| title | Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T07%3A54%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Disease%20reactivation%20after%20fingolimod%20discontinuation%20in%20two%20multiple%20sclerosis%20patients&rft.jtitle=Journal%20of%20neurology&rft.au=Ghezzi,%20A.&rft.date=2013&rft.volume=260&rft.issue=1&rft.spage=327&rft.epage=329&rft.pages=327-329&rft.issn=0340-5354&rft.eissn=1432-1459&rft_id=info:doi/10.1007/s00415-012-6744-7&rft_dat=%3Cproquest_cross%3E2732894363%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2732894363&rft_id=info:pmid/23161460&rfr_iscdi=true |